The UK Health Security Agency says that as of September 27, about 6% of sequencing tests in the UK tested positive for the Delta descendant—AY.4.2—which some scientists estimate may be 10% more infectious than original Delta.
There’s no cause for alarm just yet, but there is cause for concern. A subtype of the Delta variant of COVID-19—AY.4.2—which might be about 10% more infectious than the original Delta is contained mostly in the UK, for now. It’s uncertain how much more it can spread there, but it is spreading.
A report issued last Friday by the UK Health Security Agency says that the agency is monitoring AY.4.2 more closely. The report states that “this sublineage is currently increasing in frequency. It includes spike mutations A222V and Y145H.” About 6% of the sequencing tests in the UK as of September 27 found AY.4.2. The report states that “this estimate may be imprecise due to known sequencing issues…. Further assessment is underway.”
Francois Balloux, PhD, director at the University College London Genetics Institute, said on Twitter on Saturday that there have been 3 cases in the United States and that in Denmark, which has a vigorous sequencing system, “it reached a 2% frequency but has gone down since.” (Balloux has reportedly said that neither the A222V nor the Y145H mutations have been found in other variants of concern.)
Scott Gottlieb, MD, the former head of the Food and Drug Administration, said on Twitter Sunday that there’s “no immediate cause for alarm” about the AY.4.2. variant, but added that “urgent research” is needed “to figure out if this Delta plus is more transmissible” and can evade immunity.
Gottlieb called for a robust system to identify and characterize new variants. “This needs to be a coordinated, global priority for COVID same as similar international efforts have become standard practice in influenza,” he Tweeted.
Viruses mutate all the time. That’s what viruses do. So far, according to Scipps University's Outbreak.info, the Delta variant has averaged about 2 mutations a month; 56 in total. But at the moment, AY.4.2 is the one that concerns the scientific community the most.
Jeffrey Barrett, DPhil, the medical genomics group leader at the Wellcome Trust Sanger Institute, a not-for-profit genomics and genetics research institute, recently Tweeted that “AY.4.2 hasn’t yet spread much outside the UK, so could be a fluke (no biological advantage), but given that its apparent advantage is modest, it needs to really get established somewhere to overcome stochasticity of small numbers. That is, landing 20 Delta infections in a place with only Alpha almost guarantees that it will go on to complete replacement, whereas 20 AY.4.2 landing in an existing Delta epidemic may well fizzle.”
AY.4.2 certainly concerns Kevin Kavanagh, MD, a member of Infection Control Today®’s Editorial Advisory Board. “There is no doubt that while we celebrate and throw caution to the wind, with Delta infections rapidly decreasing in many areas of the United States, quietly and unseen SARS-CoV-2 is desperately trying to mutate in order to wreak further havoc,” says Kavanagh. “It is like watching a science fiction horror movie. I cannot tell you how it is going to end.”
Barrett seems to agree, Tweeting that the appearance of AY.4.2 “suggests the virus still has evolutionary paths to higher transmissibility open to it, and there are millions of Delta cases around the world without much sequencing coverage.”
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done
Published: July 24th 2025 | Updated: July 23rd 2025Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Pathogen Pulse: Facilities Need the SPD, Yersinia Enterocolitica Outbreak, and More
July 22nd 2025From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.